Delphi Study:
Prevention of cutaneous side effects associated with targeted cancer treatment, antibody-drug conjugates and immunotherapy
Sponsored by:
Scientific secretariat:
To participate in the second round you must be registered and have participated in the first round.
Please, sign in here:
Forgot your password?